Showing 1 - 20 results of 1,446 for search '(( 16 i decrease ) OR ((((( _ breast decrease ) OR ( _ eu decrease ))) OR ( a e decrease ))))*', query time: 0.17s Refine Results
  1. 1
  2. 2

    Metformin attenuates V-domain Ig suppressor of T-cell activation through the aryl hydrocarbon receptor pathway in Melanoma: In Vivo and In Vitro Studies by Fawaz E., Alanazi

    Published 2021
    “…This study aims to investigate the inhibitory effect of metformin on VISTA via AHR in melanoma cells (CHL-1, B16) and animal models. VISTA and AHR levels were assessed by qPCR, Western blot, immunofluorescence microscope, flow cytometry, and immunohistochemistry. …”
    Get full text
    Get full text
    Get full text
    article
  3. 3

    A slow but steady nanoLuc: R162A mutation results in a decreased, but stable, nanoLuc activity by Wesam S. Ahmed (10170053)

    Published 2024
    “…In this regard, engineering of brighter bioluminescent proteins, i.e. luciferases, has played a significant role. …”
  4. 4

    Decreased methylglyoxal-mediated protein glycation in the healthy aging mouse model of ectopic expression of UCP1 in skeletal muscle by Jinit, Masania

    Published 2023
    “…In aged HSA-mUCP1 mice, urinary MG-derived AGEs/FL ratio was decreased ca. 60% whereas there was no change in CML/FL ratio – a marker of oxidative damage. …”
    Get full text
    Get full text
    Get full text
    article
  5. 5

    Decreased methylglyoxal-mediated protein glycation in the healthy aging mouse model of ectopic expression of UCP1 in skeletal muscle by Jinit Masania (7164239)

    Published 2023
    “…In aged HSA-mUCP1 mice, urinary MG-derived AGEs/FL ratio was decreased ca. 60% whereas there was no change in CML/FL ratio – a marker of oxidative damage. …”
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Resection of liver metastases from breast cancer by Abbott, Daniel

    Published 2012
    “…On multivariate analysis, estrogen receptor–negative primary breast disease (P = .009; hazard ratio, 3.3; 95% confidence interval, 1.4–8.2) and preoperative progressive disease (P = .003; hazard ratio, 3.8; 95% confidence interval, 1.6–9.2) were associated with decreased overall survival. …”
    Get full text
    Get full text
    article
  12. 12

    CD146, a novel target of CD44-signaling, suppresses breast tumor cell invasion by Allal Ouhtit (14153256)

    Published 2017
    “…While the exact function of CD146 in breast cancer (BC) is not completely understood, substantial evidence from our work and others support the hypothesis that CD146 is a suppressor of breast tumor progression. …”
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Breast cancer cells and bone marrow mesenchymal stromal cells by Faour, Wissam H.

    Published 2017
    “…Objective The role of direct cell–cell interactions mediating selective bone metastasis by breast cancer cells (BCCs) niche is still mostly unknown. …”
    Get full text
    Get full text
    Get full text
    article
  19. 19

    Characterizing the Effect of Arginine Deprivation on Autophagic Response in Breast Cancer cells by Haidar, Fatemah

    Published 2021
    “…Residual ASS1 tumor expression corelated with increased metastasis and decreased survival in patient luminal A, Her2+ and triple-negative breast cancer. …”
    Get full text
    Get full text
    Get full text
    masterThesis
  20. 20

    Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancer by Adviti Naik (673163)

    Published 2025
    “…Silencing LDHC in breast cancer cell lines (MDA-MB-468, BT-549, HCC-1954) enhanced early T cell activation and cytolytic activity. …”